Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Medicine|July 16, 2020
Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosisMasashi Fujita, Kazumichi Abe, Manabu Hayashi, et al.
Medicine|December 9, 2022
Changes in platelet levels and prognosis in patients with acute liver failure and late-onset hepatic failureManabu Hayashi, Masashi Fujita, Kazumichi Abe, et al.
European Journal of Gastroenterology & Hepatology|April 28, 2023
Combination of psoas muscle mass index and neutrophil-to-lymphocyte ratio as a noninvasive prognostic marker in hepatocellular carcinoma patients undergoing radiofrequency ablationManabu Hayashi, Kazumichi Abe, Masashi Fujita, et al.
Plos One|November 5, 2020
Association of serum 25-hydroxyvitamin D levels with severe necroinflammatory activity and inflammatory cytokine production in type I autoimmune hepatitisKazumichi Abe, Masashi Fujita, Manabu Hayashi, et al.
Internal Medicine (Tokyo, Japan)|November 15, 2021
The Efficacy of Levocarnitine Treatment in Relieving Fatigue in Patients with Cirrhosis but without Overt Hepatic EncephalopathyKazumichi Abe, Masashi Fujita, Manabu Hayashi, et al.
Internal Medicine (Tokyo, Japan)|April 3, 2018
Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and HyponatremiaManabu Hayashi, Kazumichi Abe, Masashi Fujita, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 19, 2019
Skeletal muscle volume loss during transarterial chemoembolization predicts poor prognosis in patients with hepatocellular carcinomaMasashi Fujita, Atsushi Takahashi, Manabu Hayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 25, 2018
Changes in serum levels of leucine-rich α2-glycoprotein predict prognosis in primary biliary cholangitisManabu Hayashi, Kazumichi Abe, Masashi Fujita, et al.
Plos One|September 11, 2020
Association between serum ficolin-1 level and disease progression in primary biliary cholangitisManabu Hayashi, Kazumichi Abe, Masashi Fujita, et al.
Internal Medicine (Tokyo, Japan)|September 14, 2018
Hepatitis B Virus Reactivation in a Patient with Nonalcoholic Steatohepatitis 41 Months after Rituximab-containing ChemotherapyManabu Hayashi, Kazumichi Abe, Masashi Fujita, et al.
Pageof 9